Arsenic in public water supplies and cardiovascular mortality in Spain.

[1]  E. Guallar,et al.  Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006. , 2009, Epidemiology.

[2]  Yu Chen,et al.  Arsenic and cardiovascular disease. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  D. Stolz,et al.  Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. , 2008, The Journal of clinical investigation.

[4]  Ellen K Silbergeld,et al.  Arsenic exposure and prevalence of type 2 diabetes in US adults. , 2008, JAMA.

[5]  C. Tseng.  Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. , 2008, Atherosclerosis.

[6]  Steve Selvin,et al.  Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. , 2007, American journal of epidemiology.

[7]  D. Stolz,et al.  Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice. , 2007, Toxicology and applied pharmacology.

[8]  L. D. Del Razo,et al.  Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. , 2007, Environmental research.

[9]  L. Cameron,et al.  Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis , 2007, Environmental health : a global access science source.

[10]  F. Parvez,et al.  Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. , 2006, American journal of epidemiology.

[11]  Aruni Bhatnagar,et al.  Environmental cardiology: studying mechanistic links between pollution and heart disease. , 2006, Circulation research.

[12]  M. A. Royo-Bordonada,et al.  Riesgos asociados a la dieta occidental y al sedentarismo: la epidemia de obesidad , 2006 .

[13]  A. Sharrett,et al.  Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. , 2005, American journal of epidemiology.

[14]  Y. Hsueh,et al.  Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. , 2005, Toxicology and applied pharmacology.

[15]  D. Brooks,et al.  Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. , 2004, Toxicology and applied pharmacology.

[16]  K. Zierold,et al.  Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. , 2004, American journal of public health.

[17]  Zhongqi Cheng,et al.  Water Manganese Exposure and Children’s Intellectual Function in Araihazar, Bangladesh , 2004, Environmental health perspectives.

[18]  Michael N. Bates,et al.  Arsenic Epidemiology and Drinking Water Standards , 2002, Science.

[19]  J. Jeng,et al.  Biological Gradient Between Long-Term Arsenic Exposure and Carotid Atherosclerosis , 2002, Circulation.

[20]  N. A. Sanz,et al.  NIVEL DE ARSÉNICO EN ABASTECIMIENTOS DE AGUA DE CONSUMO DE ORIGEN SUBTERRÁNEO EN LA COMUNIDAD DE MADRID , 2001 .

[21]  M. Luster,et al.  Arsenic and atherosclerosis. , 2000, Toxicology and applied pharmacology.

[22]  M. Rahman,et al.  Diabetes mellitus associated with arsenic exposure in Bangladesh. , 1998, American journal of epidemiology.

[23]  C. Chen,et al.  Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. , 1997, Stroke.

[24]  C. Chen,et al.  Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[25]  S. Greenland.  Dose‐Response and Trend Analysis in Epidemiology: Alternatives to Categorical Analysis , 1995, Epidemiology.

[26]  A H Smith,et al.  Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. , 1994, Archives of environmental health.

[27]  M. Lai,et al.  Ingested inorganic arsenic and prevalence of diabetes mellitus. , 1994, American journal of epidemiology.

[28]  N. Breslow,et al.  Approximate inference in generalized linear mixed models , 1993 .

[29]  C. Chen,et al.  Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. , 1989, American journal of epidemiology.

[30]  Chien-Jen Chen,et al.  Atherogenicity and Carcinogenicity of High‐Arsenic Artesian Well Water: Multiple Risk Factors and Related Malignant Neoplasms of Blackfoot Disease , 1988, Arteriosclerosis.

[31]  Antonia A. Nemec,et al.  Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice , 2007, Cardiovascular Toxicology.

[32]  Shi-Yan Li,et al.  Possible involvement of NADPH oxidase and JNK in homocysteine-induced oxidative stress and apoptosis in human umbilical vein endothelial cells , 2007, Cardiovascular Toxicology.

[33]  Carmen Rodríguez Blas.  Encuesta Nacional de Salud , 2007 .

[34]  A. Gelman,et al.  Data Analysis Using Regression and Multilevel/Hierarchical Models , 2006 .

[35]  Y. Hsueh,et al.  A Review of the Epidemiologic Literature on the Role of Environmental Arsenic Exposure and Cardiovascular Diseases , 2006 .

[36]  R. García-Villanova,et al.  Arsenic in ground drinking water. The regional monitoring plan or Castilla y León (Spain) , 2005 .

[37]  J. Lillo,et al.  Arsénico en aguas subterráneas e interacción agua-roca: un ejemplo en la cuenca terciaria del Duero (Castilla y León, España) , 2004 .

[38]  J. A. Roberson,et al.  Some drinking-water disinfectants and contaminants, including arsenic. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[39]  Lourdes Chamorro,et al.  Calidad del agua de consumo en España: 1er informe nacional, año 1993/1995 , 2000 .

[40]  M. Rahman,et al.  Hypertension and arsenic exposure in Bangladesh. , 1999, Hypertension.

[41]  Á. Hernández,et al.  Estudio de los niveles de plomo, cadmio, zinc y arsénico, en aguas de la provincia de Salamanca , 1998 .

[42]  M. Lai,et al.  Increased prevalence of hypertension and long-term arsenic exposure. , 1995, Hypertension.